Publications

Skip to content

Real-world evidence

New and Noteworthy

From data to decisions: What “regulatory-grade” real-world evidence actually requires

Real-world evidence
Event recap

Flatiron launches first-of-its-kind AI-powered global prostate cancer datasets
Bigger, deeper, faster real-world data opens new horizons in hematologic oncology research
Flatiron Health launches six new hematology AI-powered longitudinal datasets

All the latest

Topics

Data management

HTA and market access

Health equity

Label expansion

Machine learning

Methodology

Post marketing requirements

Prospective study

Regulatory

Treatment patterns

Trial design

Unmet need

Content type

Article

Case study

Event recap

Podcast

Publications

Video

Webinar

Showing 9 of 0 results

From data to decisions: What “regulatory-grade” real-world evidence actually requires
- Real-world evidence
- Event recap
How real-world data from over 420,000 patients reveals treatment gaps in prostate and bladder cancer care
Flatiron launches first-of-its-kind AI-powered global prostate cancer datasets
Webinar: How breakthrough RWE is powering a new era of blood cancer research
Informing global evidence strategies with real-world data across multiple geographies
Bigger, deeper, faster real-world data opens new horizons in hematologic oncology research
Comparative outcomes of nab-paclitaxel and paclitaxel in platinum-resistant ovarian cancer (COMPASS)
Gynecologic Oncology
Three key takeaways from ESMO AI 2025
Lines of therapy across geographies: Bridging the gap between clinical practice & real-world data

Reimagining the infrastructure of cancer care

Resources
Publications
Company
Media
Careers
Contact Us

Real-World Evidence
Point of Care

Legal, Privacy, and Compliance
Cookie Settings
© FLATIRON HEALTH® 2026